Feb 11, 2020
PRIVIGEN® (Immune Globulin Intravenous (Human), 10% Liquid) Granted Orphan-Drug Designation for the Investigational Treatment of Systemic Sclerosis (SSc)
Dec 09, 2019
HIZENTRA® (Immune Globulin Subcutaneous [Human] 20% Liquid) Receives Orphan-Drug Exclusivity for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Jul 04, 2019
Grifols Announces FDA Approval of Xembify®, 20% Subcutaneous Immunoglobulin for Primary Immunodeficiencies
Jun 20, 2019
CSL Behring to showcase clinical advances and insights in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) with Hizentra ® [human normal immunoglobulin, 20%, subcutaneous], at the 2019 Peripheral Nerve Society Annual Meeting
Apr 18, 2019
The global intravenous immunoglobulin (IGIV) market was valued at $8,995 million in 2017and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025
Mar 26, 2019
Japan's Ministry of Health, Labour and Welfare Approves CSL Behring Immunoglobulins to Treat Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Jan 14, 2019
Intravenous Immunoglobulin (IVIG) Market to Reach $12.63 Bn, Globally, by 2022 at 7.1% CAGR, Says AMR
Nov 15, 2018
Immunoglobulin Market to Reach $17.50 Bn, Globally, by 2025, at 7.5% CAGR, Says Allied Market Research
Nov 08, 2018
U.S. Intravenous Immunoglobulin (IVIG) Market Analysis & Outlook (2018-2025): Stringent Regulations Pertaining to Production & Approval is Hampering Growth
Jul 23, 2018
Disarm Therapeutics Presents Data Demonstrating the Protective Effect of SARM1 Deletion on Axonal Degeneration
Jul 20, 2018
CSL Behring Hosts Symposium on Managing CIDP with Immunoglobulin, Supports 14 Scientific Posters and Two Oral Presentations at the 2018 Peripheral Nerve Society Annual Meeting
May 23, 2018
Intravenous Immunoglobulin Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2024
Apr 20, 2018
CSL Behring, Leader in Rare Diseases, Showcases Innovations in Neuromuscular Medicine (NMM) at the 2018 American Academy of Neurology Annual Meeting
Mar 21, 2018
Neuropathy Action Foundation Announces 12th Annual "Neuropathy Action Awareness Day," Largest Neuropathy-Related Patient Event In The United States
Mar 16, 2018
FDA Approves Hizentra® (Immune Globulin Subcutaneous [Human] 20% Liquid) for the Treatment of Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Nov 09, 2017
Lancet Neurology Publishes Results from CSL Behring Phase III Study of Hizentra® (Immune Globulin Subcutaneous [Human] 20% liquid) as Maintenance Therapy in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Nov 09, 2017
Global Intravenous Immunoglobulin (IGM, IGG, IGE, Immunoglobulin D (IGD) and IGA) Market, 2025
Nov 03, 2017
Repeal of Orphan Drug Tax Credit is an "Unprecedented Step"
Oct 04, 2017
Intravenous Immunoglobulin [IVIg] Market to Grow Swiftly Owing to Rise in Number of Hemorrhage Sicknesses & CIDP Cases: Million Insights
Sep 14, 2017
CSL Behring Announces FDA Approval of Privigen® [Immune Globulin Intravenous (Human), 10% Liquid] for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Adults